US74587B1017
US74587B1017
Pulse Biosciences, Inc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 350.000 | -- | -- |
| Cost of Revenue | 539.000 | -- | -- |
| Gross Profit | -189.000 | -- | -- |
| 76.750.000 | 56.257.000 | 36.4% | |
| Operating Income | -76.939.000 | -56.257.000 | 36.8% |
| Pretax Income | -72.781.000 | -53.585.000 | 35.8% |
| Net Income Common Stockholders | -72.781.000 | -53.585.000 | 35.8% |
| -- | -- | -- | |
| -- | -- | -- |